Arsenic trioxide, thalidomide and retinoid acid combination therapy in higher risk myelodysplastic syndrome patients (Q46962743)
Jump to navigation
Jump to search
scientific article published on 24 October 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Arsenic trioxide, thalidomide and retinoid acid combination therapy in higher risk myelodysplastic syndrome patients |
scientific article published on 24 October 2007 |
Statements
1 reference
Arsenic trioxide, thalidomide and retinoid acid combination therapy in higher risk myelodysplastic syndrome patients (English)
1 reference
Wen-Li Zheng
1 reference
Guang-Sen Zhang
1 reference
Yun-Xiao Xu
1 reference
Jian-Kai Shen
1 reference
Chong-Wen Dai
1 reference
Min-Fei Pei
1 reference
24 October 2007
1 reference
1 reference
32
1 reference
2
1 reference
251-254
1 reference